TITLE

JournalScan

PUB. DATE
October 2007
SOURCE
Gut;Oct2007, Vol. 56 Issue 10, p1452
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts of medical research. They include, "The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids," "Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease," and "A systematic review of the impact of volume of surgery and specialization on patient outcome."
ACCESSION #
27148481

 

Related Articles

  • Impact of Surgery on Quality of Life in Crohn's Disease. Yazdanpanah, Yazdan; Klein, Olivier; Gambiez, Luc; Baron, Philippe; Desreumaux, Pierre; Marquis, Patrick; Cortot, Antoine; Quandalle, Pierre; Colombel, Jean-Frédéric // American Journal of Gastroenterology;Oct1997, Vol. 92 Issue 10, p1897 

    Objective: Health-related quality of life (HRQOL) status is an important component in assessing the impact of disease and its treatments in patients with chronic disorders. We recently validated a HRQOL questionnaire in French patients with inflammatory bowel disease. The aim of this study was...

  • A Meta-Analysis Comparing Incidence of Recurrence and Indication for Reoperation After Surgery for Perforating Versus Nonperforating Crohn's Disease. Simillis, Constantinos; Yamamoto, Takayuki; Reese, George E.; Umegae, Satoru; Matsumoto, Koichi; Darzi, Ara W.; Tekkis, Paris P. // American Journal of Gastroenterology;Jan2008, Vol. 103 Issue 1, p196 

    OBJECTIVE: This study used meta-analytical techniques to compare the incidence of recurrence and the indication for reoperation in patients with Crohn's disease (CD) who underwent their first operation, due to perforating disease versus patients who underwent their first operation due to...

  • Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro. You-feng Guo; Xiao-bing Wang; Xiao-ying Tian; Yang Li; Bin Li; Quan Huang; Meng Zhang; Zhi Li // World Journal of Surgical Oncology;2012, Vol. 10 Issue 1, p128 

    Background: We examined the association of tumor-derived hepatocyte growth factor (HGF) with the clinicopathological features of gliomas and investigated the effect of HGF inhibition on the biological behavior of tumor cells in vitro in order to determine whether HGF is a valuable prognostic...

  • Maintenance Treatment of Postoperative Crohn's Disease. Hashash, Jana G.; Ruiz Barcia, María Jesús; Regueiro, Miguel D. // Inflammatory Bowel Disease Monitor;2013, Vol. 13 Issue 4, p135 

    The majority of Crohn's disease patients will undergo a surgical resection for a complication at some point in their lifetime. A surgical resection treats the complication but is not a cure and Crohn's disease recurrence is common. The goals of postoperative Crohn's disease management are to...

  • Rifaximin and Crohn’s Disease: A New Solution to an Old Problem? Day, A. S.; Gearry, R. B. // Digestive Diseases & Sciences;Apr2010, Vol. 55 Issue 4, p877 

    The article presents the author's comments on a study published in the current issue, which explores the outcomes of the use of rifaximin, a non-absorbable antibiotic, in Crohn's disease (CD). 68 adults with active CD were treated with rifaximin for a median of 16.6 weeks, after which two-thirds...

  • Hospitalisations and surgery in Crohn's disease. Bernstein, Charles N.; Loftus, Jr. Edward V.; Siew, C. Ng.; Lakatos, Peter L.; Moum, Bjorn // Gut;Apr2012, Vol. 61 Issue 4, p622 

    Hospitalisation and surgery are considered to be markers of more severe disease in Crohn's disease. These are costly events and limiting these costs has emerged as one rationale for the cost of expensive biologic therapies. The authors sought to review the most recent international literature to...

  • Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure. Chang-Yan Li; Chuan-Zeng Cao; Wang-Xiang Xu; Meng-Meng Cao; Fan Yang; Lan Dong; Miao Yu; Yi-Qun Zhan; Ya-Bing Gao; Wei Li; Zhi-Dong Wang; Chang-Hui Ge; Qing-Ming Wang; Rui-Yun Peng; Xiao-Ming Yang // Gut;Jun2010, Vol. 59 Issue 6, p18 

    The article discusses a study examining how recombinant human hepassocin (HPS) stimulates hepatocyte proliferation in vivo and improves survival in rats with fulminant hepatic failure. It involved an analysis of hepatocyte proliferation via thymidine incorporation and immunohistological staining...

  • Levels of vascular endothelial growth factor and hepatocyte growth factor in sera of patients with rheumatic diseases. Hashimoto, Naoaki; Iwasaki, Tsuyoshi; Kitano, Masayasu; Ogata, Atsushi; Hamano, Teruaki // Modern Rheumatology (Springer Science & Business Media B.V.);Jun2003, Vol. 13 Issue 2, p129 

    Angiogenesis plays an important role in the progression of rheumatic disease. We measured the levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in sera from patients with rheumatic diseases and investigated whether these angiogenic factors would be useful in...

  • GROWTH FACTOR THERAPY FOR VOCAL FOLD SCARRING IN A CANINE MODEL. Hirano, Shigeru; Bless, Diane M.; Welham, Nathan V.; Nagai, Hiromi; Montequin, Douglas W.; Rousseau, Bernard; Ford, Charles N. // Annals of Otology, Rhinology & Laryngology;Oct2004, Vol. 113 Issue 10, p777 

    Vocal fold scarring remains a therapeutic challenge. Hepatocyte growth factor (HGF) has strong antifibrotic activity and has proved to have therapeutic potential in restoration of scar tissues such as liver cirrhosis and lung fibrosis. The present study aimed to clarify the effects of HGF...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics